Provided by Tiger Trade Technology Pte. Ltd.

Aytu BioScience, Inc.

2.39
+0.09003.91%
Post-market: 2.390.00000.00%18:58 EST
Volume:42.89K
Turnover:103.48K
Market Cap:25.65M
PE:-1.05
High:2.50
Open:2.30
Low:2.28
Close:2.30
52wk High:3.07
52wk Low:0.9500
Shares:10.73M
Float Shares:5.69M
Volume Ratio:0.36
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2773
EPS(LYR):-2.1596
ROE:-109.23%
ROA:-0.22%
PB:1.81
PE(LYR):-1.11

Loading ...

Company Profile

Company Name:
Aytu BioScience, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
83
Office Location:
Denver Corporate Center III,Suite 920,7900 East Union Avenue,Denver,Colorado,United States
Zip Code:
80237
Fax:
- -
Introduction:
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.

Directors

Name
Position
John A. Donofrio, Jr.
Chairman of the Board and Director
Joshua R. Disbrow
Chief Executive Officer and Director
Abhinav Jain
Director
Carl C. Dockery
Director
Vivian H. Liu
Director

Shareholders

Name
Position
Joshua R. Disbrow
Chief Executive Officer and Director
Ryan J. Selhorn
Chief Financial Officer and Corporate Secretary and Treasurer
Greg Pyszczymuka
Chief Commercial Officer
Jarrett T. Disbrow
Chief Business Officer